Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Therapy Perspectives
Published in: Drugs & Therapy Perspectives 1/2023

01-01-2023 | Intense Pulsed Light | Practical Issues and Updates

Limit acne damage with lasers and light therapy

Authors: Caroline Fenton, Connie Kang

Published in: Drugs & Therapy Perspectives | Issue 1/2023

Login to get access

Abstract

Active acne, especially inflammatory acne, and subsequent hypopigmentation or erythematous scarring causes significant distress, particularly in adolescents. The outcomes of mostly small trials, and expert opinion, highlights lasers and light devices as relatively fast, effective treatment options. Numerous device configurations exist, and any of the ablative options (e.g. the carbon dioxide laser), non-ablative or vascular lasers and light devices may be appropriate, according to the target lesions. Further investigation is needed, with larger trials.
Literature
1.
Li MK, Liu C, Hsu JTS. The use of lasers and light devices in acne management: an update. Am J Clin Dermatol. 2021;22(6):785–800.CrossRef
2.
Salameh F, Shumaker PR, Goodman GJ, et al. Energy-based devices for the treatment of acne scars: 2022 international consensus recommendations. Lasers Surg Med. 2022;54(1):10–26.CrossRef
3.
Conforti C, Chello C, Giuffrida R, et al. An overview of treatment options for mild-to-moderate acne based on American Academy of Dermatology, European Academy of Dermatology and Venereology, and Italian Society of Dermatology and Venereology guidelines. Dermatol Ther. 2020;33(4):e13548.CrossRef
4.
Amiri R, Khalili M, Mohammadi S, et al. Treatment protocols and efficacy of light and laser treatments in post-acne erythema. J Cosmet Dermatol. 2022;21(2):648–56.CrossRef
5.
Wall TL. Current concepts: laser treatment of adult vascular lesions. Semin Plast Surg. 2007;21(3):147–58.CrossRef
6.
Anyachukwu CC, Onyeso OKK. Efficacy of adjunct (laser) therapy to topical agents among Southern Nigerian acne vulgaris patients. Acupunct Relat Ther. 2014;2(4):66–70.CrossRef
7.
Mahran HG. Efficacy of twelve sessions of 905 nm infrared laser on acne vulgaris. Ann Clin Anal Med. 2020;11:191–5.
8.
Jung JY, Hong JS, Ahn CH, et al. Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension. J Am Acad Dermatol. 2012;66(4):626–33.CrossRef
9.
Bakus AD, Yaghmai D, Massa MC, et al. Sustained benefit after treatment of acne vulgaris using only a novel combination of long-pulsed and Q-switched 1064-nm Nd:YAG lasers. Dermatol Surg. 2018;44(11):1402–10.CrossRef
10.
Monib KMED, Hussein MS. Nd:YAG laser vs IPL in inflammatory and noninflammatory acne lesion treatment. J Cosmet Dermatol. 2020;19(9):2325–32.CrossRef
11.
Chalermsuwiwattanakan N, Rojhirunsakool S, Kamanamool N, et al. The comparative study of efficacy between 1064-nm long-pulsed Nd:YAG laser and 595-nm pulsed dye laser for the treatment of acne vulgarisAdv Online Public. J Cosmet Dermatol. 2020;20(7):2108–15.CrossRef
12.
Moneib H, Tawfik AA, Youssef SS, et al. Randomized split-face controlled study to evaluate 1550-nm fractionated erbium glass laser for treatment of acne vulgaris-an image analysis evaluation. Dermatol Surg. 2014;40(11):1191–200.CrossRef
13.
Gao L, Wang L, Li K, et al. Treatment of acne vulgaris using 1,565 nm non-ablative fractional laser in combination with isotretinoin and pricking blood therapy. J Dermatol Treat. 2020;33(2):749–55.CrossRef
14.
Shin JU, Lee SH, Jung JY, et al. A split-face comparison of a fractional microneedle radiofrequency device and fractional carbon dioxide laser therapy in acne patients. J Cosmet Laser Ther. 2012;14(5):212–7.CrossRef
15.
Wang B, Wu Y, Luo YJ, et al. Combination of intense pulsed light and fractional CO2 laser treatments for patients with acne with inflammatory and scarring lesions. Clin Exp Dermatol. 2013;38(4):344–51.CrossRef
16.
Liu G, Pan C, Li K, et al. Phototherapy for mild to moderate acne vulgaris with portable blue and red led. J Innov Opt Health Sci. 2011;4(1):45–52.CrossRef
17.
Nestor MS, Swenson N, MacRi A, et al. Efficacy and tolerability of a combined 445 nm and 630 nm over-the-counter light therapy mask with and without topical salicylic acid versus topical benzoyl peroxide for the treatment of mild-to-moderate acne vulgaris. J Clin Aesthet Dermatol. 2016;9(3):25–35.
18.
Neinaa YME, Al-Khayat LA, Suliman GAM, et al. Fractional carbon dioxide laser-assisted delivery of lyophilized-growth factors is a promising treatment modality of post-acne scars. Dermatol Ther. 2020;33(6): e14488.CrossRef
19.
Alexiades M. Randomized, double-blind, split-face study evaluating fractional ablative erbium:YAG laser-mediated trans-epidermal delivery of cosmetic actives and a novel acoustic pressure wave ultrasound technology for the treatment of skin aging, melasma, and acne scars. J Drugs Dermatol. 2015;14(11):1191–8.
20.
Lekakh O, Mahoney AM, Novice K, et al. Treatment of acne vulgaris with salicylic acid chemical peel and pulsed dye laser: a split face, rater-blinded, randomized controlled trial. J Lasers Med Sci. 2015;6(4):167–70.CrossRef
21.
Kang A, Lyons A, Herrmann J, et al. Treatment of moderate-to-severe facial acne vulgaris with solid-state fractional 589/1,319-nm laser. J Clin Aesthet Dermatol. 2019;12(3):28–31.
22.
Amjad I, Saleemi A, Rana AR. Therapeutic effects of blue light for the facial acne vulgaris in mild and moderate conditions. Indo Am J Pharm Sci. 2018;5(6):5848–51.
23.
Wheeland RG, Koreck A. Safety and effectiveness of a new blue light device for the self-treatment of mild-to-moderate acne. J Clin Aesthet Dermatol. 2012;5(5):25–31.
24.
Cheema AN, Ameen U, Javaid R, et al. Efficacy and safety of blue light versus 4% topical benzoyl peroxide in mild to moderate acne. J Pak Assoc Dermatol. 2018;28(1):79–84.
25.
de Vries FMC, Meulendijks AM, Driessen RJB, et al. The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: a systematic review and best-evidence synthesis. J Eur Acad Dermatol Venereol. 2018;32(7):1195–203.CrossRef
26.
Hamilton FL, Car J, Lyons C, et al. Laser and other light therapies for the treatment of acne vulgaris: systematic review. Br J Dermatol. 2009;160(6):1273–85.CrossRef
27.
Liu LH, Fan X, An YX, et al. Randomized trial of three phototherapy methods for the treatment of acne vulgaris in Chinese patients. Photodermatol Photoimmunol Photomed. 2014;30(5):246–53.CrossRef
28.
Deshpande AJ. Efficacy and safety evaluation of high-density intense pulsed light in the treatment of grades II and IV acne vulgaris as monotherapy in dark-skinned women of child bearing age. J Clin Aesthet Dermatol. 2018;11(4):43–8.
29.
Patidar M, Deshmukh A, Khedkar M. Efficacy of intense pulsed light therapy in the treatment of facial acne vulgaris: comparison of two different fluences. Indian J Dermatol. 2016;61(5):545–9.CrossRef
30.
Lu L, Shi M, Chen Z. Efficacy of IPL therapy for the treatment of acne vulgaris: a meta-analysis. J Cosmet Dermatol. 2020;19(10):2596–605.CrossRef
31.
Li Y, Zhu J, Zhang Y, et al. Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: a randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects. Lasers Med Sci. 2021;36(3):657–65.CrossRef
32.
Tang X, Li C, Ge S, et al. Efficacy of photodynamic therapy for the treatment of inflammatory acne vulgaris: a systematic review and meta-analysis. J Cosmet Dermatol. 2020;19(1):10–21.CrossRef
33.
Nicklas C, Rubio R, Cárdenas C, et al. Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-a simple, blind, randomized, and controlled trial. Photodermatol Photoimmunol Photomed. 2019;35(1):3–10.
Metadata
Title
Limit acne damage with lasers and light therapy
Authors
Caroline Fenton
Connie Kang
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Drugs & Therapy Perspectives / Issue 1/2023
Print ISSN: 1172-0360
Electronic ISSN: 1179-1977
DOI
https://doi.org/10.1007/s40267-022-00970-2

Other articles of this Issue 1/2023

Drugs & Therapy Perspectives 1/2023 Go to the issue

Practical Issues and Updates

Monkeypox may be managed with smallpox vaccines and antivirals

Commentary

The role of professional socialisation in reducing drug-related problems during COVID-19: a new insight for future pandemics

Practical Issues and Updates

Consider cannabinoids as an individual therapeutic trial in nociplastic pain

Original Research Article

Disparities in erythropoiesis-stimulating agent use after changes in medicare reimbursement and implementation of a risk evaluation and mitigation strategy

Disease Management

Management of central neuropathic pain involves many drugs but few have proven efficacy

Correction

Correction to: Amantadine extended release capsules (GOCOVRI®) in Parkinson’s disease: a profile of its use in the USA